(Q33667548)

28 July 2017

4 references

22 June 2019

19 September 2019

11 September 2020

13 September 2020

New business models for antibiotic innovation (English)

1 reference

biomedical investigative technique

28 July 2017

main subject

1 reference

19 September 2019

1 reference

11 September 2020

1 reference

13 September 2020

Anthony D So

1

1 reference

28 July 2017

Tejen A Shah

series ordinal

2

1 reference

28 July 2017

publication date

19 March 2014

1 reference

Upsala Journal of Medical Sciences

28 July 2017

1 May 2014

4 references

22 June 2019

19 September 2019

11 September 2020

13 September 2020

5 references

28 July 2017

22 June 2019

19 September 2019

11 September 2020

13 September 2020

119

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

176-180

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

28 July 2017

copyright license

4 references

22 June 2019

19 September 2019

11 September 2020

Antibiotic resistance-the need for global solutions

13 September 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

Towards new business models for R&D for novel antibiotics.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

Novel classes of antibiotics or more of the same?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

Deaths: final data for 2005.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

Drugs for bad bugs: confronting the challenges of antibacterial discovery

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

The historical delivery of antibiotics from microbial natural products--can history repeat?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

Antimicrobial drug development--the past, the present, and the future

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

Why is big Pharma getting out of antibacterial drug discovery?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

The price of innovation: new estimates of drug development costs

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4034556

Antibacterial discovery and development--the failure of success?

14 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.3109%2F03009734.2014.898717

The FDA and the case of Ketek

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3109%2F03009734.2014.898717

PUBLIC HEALTH: Responding to Market Failures in Tuberculosis Control

21 January 2018

1 reference

12 December 2020

Success rates for new drugs entering clinical testing in the United States

1 reference

12 December 2020

Ketek--the FDA perspective

1 reference

12 December 2020

Physicochemical properties of antibacterial compounds: implications for drug discovery

1 reference

12 December 2020

Portfolio analysis and R&D decision making

1 reference

12 December 2020

The antibiotics market

1 reference

12 December 2020

3Rs for innovating novel antibiotics: sharing resources, risks, and rewards

1 reference

12 December 2020

Putting a price on biotechnology

1 reference

12 December 2020

10.3109/03009734.2014.898717

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference